CTRI/2011/05/001764尚未招募3 期
A Randomized, Open Label, Parallel Group, Placebo-controlled, Efficacy and Safety Study of RTFIT Tablets in patients with alcoholic liver disease. - Nil
Zota Healthcare Ltd0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •i.Patients of either sex between 20-60 years of age.
- •ii.Patients having history of alcoholic hepatitis, non alcoholic seatohepatitis (NASH), viral hepatitis (Jaundice), sclerosis of liver and drug induced hepatitis.
排除标准
- •i.Pregnancy or lactation
- •ii.Fasting glucose levels greater than 250 mg per deciliter
- •iii.Contraindication to liver biopsy
- •iv.Concomitant disease with reduced life expectancy
- •v.Hepatic failure
- •vi.Severe psychiatric conditions
- •vii.Drug dependence
- •viii.History of hemochromatosis, Wilson Disease, cholangitis, other chronic disease, renal insufficiency
- •ix.A known hypersensitivity to Taurine and Methionine or its structurally related compounds
研究者
相似试验
进行中（未招募）
1 期
A randomized, parallel group, placebo-controlled, double blind study to asses the safety and tolerability of SB 681323 at 7.5 mg daily dose for 28 days and its effect on the levels of serum C-reactive protein (CRP) in subjects with rheumatois arthritis”EUCTR2005-002219-26-HUGlaxoSmithKline
进行中（未招募）
1 期
An efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)Mild to Moderate Alzheimer's DiseaseMedDRA version: 15.1 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852EUCTR2011-003151-20-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co.,Inc.2,211
进行中（未招募）
1 期
An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)EUCTR2011-003151-20-BEMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.1,960
进行中（未招募）
1 期
An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)EUCTR2011-003151-20-ESMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.2,211
进行中（未招募）
1 期
An Efficacy and Safety Trial of MK-8931 in Mild to Moderate AD (EPOCH)mild to moderate Alzheimer's DiseaseMedDRA version: 19.0Level: LLTClassification code 10001896Term: Alzheimer's diseaseSystem Organ Class: 100000004852EUCTR2011-003151-20-HUMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.1,960